Further characterization of malignant glioma-derived vascular permeability factor.
Explore this paper's citation graph
Summary
Evidence is provided against VPF being one of the more commonly known serum-derived permeability mediators and the presence of at least one essential disulfide bond in this molecule is confirmed.
- Type
- article
- Published
- 1988-08-01
- Cited by
- 113
- References
- 35
- OpenAlex
- https://openalex.org/W1974005709
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:9076513
Keywords
Dithiothreitol, Sepharose, Affinity chromatography, Aprotinin, Kallikrein
References
- Presidental address. Neuropathological aspects of brain edema.
- Correlation of tumor plasminogen activator with peritumoral cerebral edema. A CT and biochemical study.
- Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells.
- Protein measurement with the Folin phenol reagent.
- Brain tumors and the blood—brain barrier
- Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
- The large apparent work capability of the blood‐brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat
- The blood-brain barrier to proteins under normal and pathological conditions.
- Actinomycin D suppresses the protective effect of dexamethasone in rats affected by global cerebral ischemia.
- Polyamine and prostaglandin markers in focal cerebral ischemia.
- Vascular ultrastructure in human meningiomas and schwannomas.
- Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits.
- Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator.
- Efficacy and safety of tissue plasminogen activator.
- Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors.
- Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
- Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor.
- Leukotrienes increase blood‐brain barrier permeability following intraparenchymal injections in rats
- Vasogenic brain oedema. New aspects in its formation, resolution and therapy.
- Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides.
Cited by
- Human cerebral endothelium: Isolation and characterization of cells derived from microvessels of non-neoplastic and malignant glial tissue
- Microvascular endothelial cell heterogeneity: Interactions with leukocytes and tumor cells
- Emerging therapies for malignant glioma
- Glial ontogeny and glial neoplasia: The search for closure
- Vascular Permeability Factor Expression in Cerebellar Hemangioblastomas: Correlation with Tumor-associated Cysts
- Malignant cerebral edema and intracranial hypertension.
- Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.
- Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.
- Vascular endothelial growth factor
- Peritumoural Brain Oedema
- Expression of Vascular Permeability Factor in Glioblastoma Specimens: Correlation with Tumor Vascular Endothelial Surface and Peritumoral Edema
- Angiogenesis in Brain Tumors
- Endothelial Cell Dysfunctions
- Bevacizumab and intraocular tumors: an intriguing paradox
- Anti-angiogenic therapy in uveal melanoma.
- Étude des mécanismes cellulaires activés par l'Angiopoïétine-1 et le VEGF régulant la perméabilité et la migration endothéliales
- Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
- A pial window model for the intracranial study of human glioma microvascular function.
- Amplification of the anonymous marker D17S67 in malignant astrocytomas
- Vascular Endothelial Growth Factor in Thyroid Cancers
Related papers
- Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
- Competitive Parabolic Inhibition of Rat Tissue Kallikrein by Aprotinin
- Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases
- Similarity between a kininogenase (kallikrein) from human large intestine and human urinary kallikrein.
- Kallikrein inhibitors.
- Inhibitory effects of aprotinin on kallikrein and kininases in dog's blood
- The effects of human kallikrein and aprotinin on nonmalignant and malignant cell growth.
- Histochemical localization of kallikrein-like pro-phe-arg-naphthylester esterase activity in the rat kidney
- Isolation of an enzymatically active glandular kallikrein from human plasma by immunoaffinity chromatography.
- Some properties of human pancreatic kallikrein and comparison with human trypsins and porcine kallikrein.